Krystal Biotech, Inc. (BIT:1KRYS)

Krystal Biotech Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Cap	4,519	3,882	3,015	1,756	1,517	1,018
Market Cap Growth	-2.25%	28.77%	71.63%	15.75%	49.07%	23.08%
Enterprise Value	3,821	3,373	2,562	1,436	1,146	787.35
PE Ratio	36.17	52.22	318.10	-14.43	-22.35	-35.09
Forward PE	25.57	33.31	-	-	-	-
PS Ratio	14.77	15.53	69.09	-	-	-
PB Ratio	5.10	4.77	4.50	3.91	2.97	4.05
P/TBV Ratio	3.99	4.92	4.42	3.87	2.62	3.86
P/FCF Ratio	28.62	37.85	-34.82	-13.29	-15.17	-28.90
P/OCF Ratio	27.16	36.55	-39.45	-20.29	-36.78	-45.35
EV/Sales Ratio	12.36	13.49	58.73	-	-	-
EV/EBITDA Ratio	28.73	54.13	-28.68	-11.77	-20.34	-29.37
EV/EBIT Ratio	29.26	59.66	-27.14	-11.50	-19.51	-27.73
EV/FCF Ratio	24.20	32.89	-29.60	-10.87	-11.46	-22.35
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	0.06	0.10	-0.08	-0.06	-0.12	-0.37
Debt / FCF Ratio	0.05	0.06	-0.08	-0.06	-0.07	-0.28
Asset Turnover	0.33	0.31	0.07	0	0	0
Inventory Turnover	0.83	1.20	0.89	-	-	-
Quick Ratio	9.13	6.89	17.35	13.14	17.02	17.56
Current Ratio	9.68	7.28	17.76	13.30	17.18	17.80
Return on Equity (ROE)	14.77%	10.34%	1.68%	-25.09%	-15.71%	-13.00%
Return on Assets (ROA)	12.03%	6.55%	-13.51%	-24.51%	-14.57%	-12.70%
Return on Capital (ROIC)	36.23%	20.07%	-43.18%	-80.37%	-59.60%	-114.49%
Return on Capital Employed (ROCE)	15.14%	7.56%	-16.69%	-25.69%	-15.24%	-13.17%
Earnings Yield	2.76%	1.91%	0.31%	-6.93%	-4.47%	-2.85%
FCF Yield	3.49%	2.64%	-2.87%	-7.52%	-6.59%	-3.46%
Buyback Yield / Dilution	-0.23%	-0.60%	-5.79%	-1.73%	-20.17%	-9.98%
Total Shareholder Return	-	-0.60%	-5.79%	-1.73%	-20.17%	-9.98%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.